Journal profile · Medicine-Immunology and Allergy
Clinical and Molecular Allergy
ISSN 1476-7961 · Springer Nature · United Kingdom
Clinical and Molecular Allergy: fully open access; APC about USD 2,490; review about 13 weeks (community reports); 0 articles in 2025; indexed in Scopus; the journal's website says submissions are paused or closed.
The journal's website says submissions are paused or closed: Clinical and Molecular Allergy is now archived and no longer receiving submissions with this publisher. All articles published in the journal during its time with Springer will remain fully searchable through our websites. Source ↗Publisher website ·
Scope
Aims, scope and focus
Clinical and Molecular Allergy is published by Springer Nature. By OpenAlex counts of its recent articles, its largest topics are Allergic Rhinitis and Sensitization, Asthma and respiratory diseases and Food Allergy and Anaphylaxis Research, together about 59.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Medicine-Immunology and Allergy
Main research topics OpenAlex counts of recent articles; shares are approximate
- Allergic Rhinitis and SensitizationMedicine21%
- Asthma and respiratory diseasesMedicine20.6%
- Food Allergy and Anaphylaxis ResearchMedicine18%
- Drug-Induced Adverse ReactionsMedicine6.8%
- Mast cells and histamineImmunology and Microbiology4.4%
- Dermatology and Skin DiseasesMedicine4.1%
- Occupational exposure and asthmaMedicine3.3%
- Contact Dermatitis and AllergiesMedicine2.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Immunology and Allergy | Q1 | 47/234 | 80th |
| Immunology | Q1 | 53/243 | 78th |
| Molecular Biology | Q1 | 92/414 | 77th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 8.7LetPub ·
- SJR 2026-06
- 0.69LetPub ·
- SNIP 2026-06
- 1.11LetPub ·
- h-index
- 52OpenAlex ·
- i10-index
- 216OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 295 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 0 | 0 | 427 |
| 2025 | 0 | 0 | 603 |
| 2024 | 1 | 1 | 753 |
| 2023 | 8 | 8 | 848 |
| 2022 | 15 | 15 | 860 |
| 2021 | 27 | 27 | 922 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 13 weeksLetPub ·
- Peer review
- Anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,490 / EUR 2,090 / GBP 1,790 | — | — | |
| LetPub | GBP 1,790 / USD 2,490 / EUR 2,090 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websitePeer review
- Peer review
Journal is archived and no longer accepting submissions with this publisher Model summary
Clinical and Molecular Allergy is now archived and no longer receiving submissions with this publisher.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 1476-7961
- Official links
- Journal homepage ↗OpenAlex
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Clinical and Molecular Allergy
How long does peer review take at Clinical and Molecular Allergy?
Authors report an average review time of about 13 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Clinical and Molecular Allergy?
According to LetPub and DOAJ records, Clinical and Molecular Allergy is indexed in Scopus.
Is Clinical and Molecular Allergy open access, and what is the APC?
Clinical and Molecular Allergy is a fully open-access journal. APC about USD 2,490.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .